TY - JOUR
T1 - Improved viability and reduced apoptosis in sub-zero 21-hour preservation of transplanted rat hearts using anti-freeze proteins
AU - Amir, Gabriel
AU - Rubinsky, Boris
AU - Basheer, Sheick Yousif
AU - Horowitz, Liana
AU - Jonathan, Leor
AU - Feinberg, Micha S.
AU - Smolinsky, Aram K.
AU - Lavee, Jacob
N1 - Funding Information:
This study was partially funded by an unconditional grant provided by A/F Protein, Inc. Dr. Rubinsky has a commercial interest in the company.
PY - 2005/11
Y1 - 2005/11
N2 - Background: Freeze-tolerant fish survive sub-zero temperatures by non-colligatively lowering the freezing temperature of their body fluids using anti-freeze proteins (AFPs). We sought to evaluate and compare the effects of prolonged sub-zero cryopreservation of transplanted rat hearts using AFP I or AFP III. Methods: Two heterotopic rat heart transplantation protocols were used. In Protocol 1 (n = 104), hearts (n = 8/group) were preserved for 12, 18 and 24 hours in University of Wisconsin solution (UW) at 4°C, UW at -1.3°C, UW/AFP I at -1.3°C and UW/AFP III at -1.3°C, with and without nucleation. Post-operative evaluation consisted of visual viability scoring of the hearts after 60 minutes. Protocol 2 (n = 58) involved evaluation of 24-hour post-transplant viability, echocardiography (fractional shortening [FS], left ventricular end-systolic and -diastolic diameter [ESD, EDD] and anterior and posterior wall systolic and diastolic thickness [AWT-S, AWT-D, PWT-S, PWT-D]), TUNEL staining and electron microscopy (EM) findings for hearts preserved for 18, 21 and 24 hours in UW at 4°C or UW/AFP III at -1.3°C. Results: Hearts preserved in UW at -1.3°C with nucleation froze and died. Three of 8 hearts preserved in UW at 4°C for 24 hours died, whereas all hearts preserved at -1.3°C survived. Hearts preserved in UW/AFP for 18 and 24 hours at -1.3°C had superior viability scores compared with those in UW at 4°C. Hearts in AFP III at -1.3°C displayed greater AWT-S and AWT-D (3.5 ± 0.2 vs 2.4 ± 0.2, p < 0.05, and 3.5 ± 0.2 vs 2.2 ± 0.2, p < 0.05, respectively) after 18-hour preservation. In the 21-hour preservation group, AFP-treated hearts displayed improved echocardiographic systolic contraction indices, including: improved FS (27 ± 3.7 vs 15 ± 4, p = 0.04); diminished ESD (0.28 ± 0.57 vs 0.47 ± 0.6, p < 0.05); greater AWT-S (3.4 ± 0.18 vs 2.8 ± 0.2, p < 0.05); and fewer positively TUNEL-stained nuclei per specimen (35 ± 14 vs 5.3 ± 2.7, p = 0.04). Also, improved EM scores were noted compared with UW at 4°C. Conclusions: In prolonged sub-zero cryopreservation, AFPs protect the heart from freezing, improve survival and hemodynamics, and reduce apoptotic cell death.
AB - Background: Freeze-tolerant fish survive sub-zero temperatures by non-colligatively lowering the freezing temperature of their body fluids using anti-freeze proteins (AFPs). We sought to evaluate and compare the effects of prolonged sub-zero cryopreservation of transplanted rat hearts using AFP I or AFP III. Methods: Two heterotopic rat heart transplantation protocols were used. In Protocol 1 (n = 104), hearts (n = 8/group) were preserved for 12, 18 and 24 hours in University of Wisconsin solution (UW) at 4°C, UW at -1.3°C, UW/AFP I at -1.3°C and UW/AFP III at -1.3°C, with and without nucleation. Post-operative evaluation consisted of visual viability scoring of the hearts after 60 minutes. Protocol 2 (n = 58) involved evaluation of 24-hour post-transplant viability, echocardiography (fractional shortening [FS], left ventricular end-systolic and -diastolic diameter [ESD, EDD] and anterior and posterior wall systolic and diastolic thickness [AWT-S, AWT-D, PWT-S, PWT-D]), TUNEL staining and electron microscopy (EM) findings for hearts preserved for 18, 21 and 24 hours in UW at 4°C or UW/AFP III at -1.3°C. Results: Hearts preserved in UW at -1.3°C with nucleation froze and died. Three of 8 hearts preserved in UW at 4°C for 24 hours died, whereas all hearts preserved at -1.3°C survived. Hearts preserved in UW/AFP for 18 and 24 hours at -1.3°C had superior viability scores compared with those in UW at 4°C. Hearts in AFP III at -1.3°C displayed greater AWT-S and AWT-D (3.5 ± 0.2 vs 2.4 ± 0.2, p < 0.05, and 3.5 ± 0.2 vs 2.2 ± 0.2, p < 0.05, respectively) after 18-hour preservation. In the 21-hour preservation group, AFP-treated hearts displayed improved echocardiographic systolic contraction indices, including: improved FS (27 ± 3.7 vs 15 ± 4, p = 0.04); diminished ESD (0.28 ± 0.57 vs 0.47 ± 0.6, p < 0.05); greater AWT-S (3.4 ± 0.18 vs 2.8 ± 0.2, p < 0.05); and fewer positively TUNEL-stained nuclei per specimen (35 ± 14 vs 5.3 ± 2.7, p = 0.04). Also, improved EM scores were noted compared with UW at 4°C. Conclusions: In prolonged sub-zero cryopreservation, AFPs protect the heart from freezing, improve survival and hemodynamics, and reduce apoptotic cell death.
UR - http://www.scopus.com/inward/record.url?scp=27844523689&partnerID=8YFLogxK
U2 - 10.1016/j.healun.2004.11.003
DO - 10.1016/j.healun.2004.11.003
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 16297800
AN - SCOPUS:27844523689
SN - 1053-2498
VL - 24
SP - 1915
EP - 1929
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
IS - 11
ER -